Result Summaries: emicerfont
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| CRI105626 | phase 2 | A randomised, double-blind, placebo-controlled, crossover study to evaluate efficacy and safety of the CRF1 receptor antagonist GW876008 in patients with Irritable Bowel Syndrome (0 citation(s)) |  |